Sébastien Hébert
Chercheur universitaire
Axe Neurosciences
Publications
Voir tout-
article Lala Bouali M, Kezai AM, Bazin M, Badiane PY, Eskandari N, Lévesque V, Robillard J, Côté SD, Soulet D, Tremblay C, Calon F, Morin F, Vallières L, Hébert SS
Natural microbial enrichment modulates microglial states and transcriptional programs relevant to Alzheimers disease
Front Immunol 17 2026.
-
article Calon F, Otaegui L, Bouali ML, Hébert SS
Are mouse models of Alzheimers disease truly flawed, or are we misusing them
Neuroscience 614 2026.
-
article Cottez RJ, Peyrot C, Denis HL, Tremblay C, Loiselle A, Dallaire-Théroux C, Filali-Mouhim A, Hébert SS, Leclerc N, Blennow K, Zetterberg H and and Kergoat MJ, Calon F, Pichet Binette A
Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort
Alzheimers Dement 22 (6), 2026.
Projets
- Preclinical safety, pharmacokinetics, pharmacodynamics, and efficiency of microRNA oligonucleotides for Alzheimer's disease, du 2022-04-01 au 2027-03-31
- Consortium pour l’identification précoce de la maladie d’Alzheimer (CIMA-Q) : renforcer l’intersectorialité, le rayonnement et le potentiel de découverte., du 2024-04-01 au 2028-03-31
- Into the (re-) wild: moving beyond lab-raised mice in order to make EAE more reflective of human MS, du 2026-04-01 au 2028-03-31
- Preclinical safety, pharmacokinetics, pharmacodynamics, and efficiency of microRNA oligonucleotides for Alzheimer's disease, du 2020-03-01 au 2025-03-31
- Importance of non-canonical microRNAs in the mammalian brain, du 2020-04-01 au 2026-03-31
- Vascular MicroRNA-212 in CAA and Alzheimer's disease, du 2023-09-22 au 2025-08-31